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Abstract
The coronavirus infectious bronchitis virus (IBV) nucleocapsid (N) protein is an RNA binding protein which is phosphorylated at two
conserved clusters. Kinetic analysis of RNA binding indicated that the C-terminal phosphorylation cluster was involved in the recognition of viral
RNA from non-viral RNA. The IBV N protein has been found to be essential for the successful recovery of IBV using reverse genetics systems.
Rescue experiments indicated that phosphorylated N protein recovered infectious IBV more efficiently when compared to modified N proteins
either partially or non-phosphorylated. Our data indicate that the phosphorylated form of the IBV N protein plays a role in virus biology.
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One of the fundamental stages in the life cycle of
coronaviruses and other RNA viruses is the recognition of
viral genomic RNA by the virus encoded nucleocapsid protein,
for roles in RNA synthesis, encapsidation, packaging and in the
correct folding of the RNA molecule. Phosphorylation of the
nucleocapsid protein is thought to regulate many of these events
although precise roles remain unclear. Coronaviruses are a
group of positive strand RNA viruses which cause principally
respiratory and gastro-intestinal infections and include the
severe acute respiratory syndrome coronavirus (SARS-CoV)
(Peiris et al., 2004) and avian infectious bronchitis virus (IBV)
(Cavanagh, 2005).
Coronavirus genomes are approximately 30 kb in length,
making them the largest RNA genomes so far discovered. Both
RNA replication and mRNA transcription occur in virus
infected cells and a series of subgenomic mRNA molecules⁎ Corresponding author. Institute of Molecular and Cellular Biology, Faculty
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doi:10.1016/j.virol.2007.08.016are synthesized by the viral replicase via a discontinuous
transcription mechanism (Enjuanes et al., 2006a; Pasternak
et al., 2006; Sawicki et al., 2007), in which a viral leader
sequence, derived from the 5′ end of the genome, is added to the
5′ end of each subgenomic mRNA (Masters, 2006). Adjacent to
the leader sequence is a transcription regulatory sequence (TRS)
which also precedes each open reading frame along the genome.
Genetic analysis suggests that the TRS and flanking sequences
are involved in the modulation of transcription (Alonso et al.,
2002; Hiscox et al., 1995; Sola et al., 2005; Van Marle et al.,
1995; Zuniga et al., 2004). The TRS has been shown to act as a
high affinity binding site for the coronavirus nucleocapsid (N)
protein suggesting a role for N protein in transcription (Baric
et al., 1988; Nelson et al., 2000; Spencer and Hiscox, 2006a;
Stohlman et al., 1988). Although replication can take place
without N protein it does so at reduced efficiency (Almazan
et al., 2004; Schelle et al., 2005). Furthermore N protein has
been shown to co-localize with coronavirus replication com-
plexes in the cytoplasm at early points post-infection (Denison
et al., 1999; Van der Meer et al., 1999). Moreover, N protein is
required for the efficient rescue of coronavirus genomic RNA
from cDNA clones (Almazan et al., 2004; Coley et al., 2005;
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shown to be essential for the rescue of IBV using at least two
different types of reverse genetics systems (Britton et al., 2005;
Casais et al., 2001; Youn et al., 2005a,b).
Coronavirus N proteins have roles in both virus RNA syn-
thesis and modulating host cell processes and phosphorylation
may regulate these processes by exposing various functional
motifs (You et al., 2005, 2007). By amino acid sequence
comparison coronavirus N proteins can be separated into three
regions of conserved homology (Parker and Masters, 1990).
Situated within these regions are motifs which play a role in both
aspects of virus biology. For example, IBVN protein contains an
RNA binding site (Tan et al., 2006), a nucleolar localization
signal (Reed et al., 2006) and a nuclear export signal (Reed et al.,
2007). These latter two signals modulate its dynamic trafficking
(Cawood et al., 2007) between the cytoplasm (the site of viral
RNA synthesis) and the nucleolus, suggesting a nucleolar aspect
to the virus life cycle (Hiscox, 2007).
Recent studies have shown that the N-terminal region RNA
binding site of IBV N protein has the potential to form an
electrostatic interaction with RNA (Fan et al., 2005). This was
subsequently confirmed by measuring dynamic interactions
(using surface plasmon resonance (SPR)) (Spencer and Hiscox,
2006a) and raised the possibility that N protein initially bound
viral RNAvia a weak electrostatic interaction (a ‘lure’ step) and
that a ‘lock’ step was facilitated by specific high affinity binding
to structures on the viral RNA such as the TRS (Spencer and
Hiscox, 2006a). This latter stage being similar to the recognition
of the hantavirus vRNA panhandle by its nucleocapsid protein
(Mir et al., 2006) or the interaction of HIV-1 Rev protein with
loop A (Greatorex et al., 2006). Again, similar to the ability of
the hantavirus nucleocapsid protein (Mir and Panganiban,
2006), the coronavirus N protein has also been shown to have
RNA chaperone activity (Zuniga et al., 2007).
IBV N protein has a predicted molecular weight of 45 kDa,
although migrates under SDS–PAGE with a mobility of
∼50 kDa, suggestive of post-translational modifications
(Chen et al., 2003), which was confirmed by the incorporation
of 32P-orthophosphate into N protein during infection and was
also found in virions (Jayaram et al., 2005). Although
coronavirus N proteins were predicted to be phosphorylated at
multiple serine residues, mass spectroscopic analyses identified
two regions of phosphorylation on the IBV N protein (when
over-expressed) which are located at two conserved amino acid
clusters, Ser190 and Ser192 and Thr378 and Ser379 (Chen et al.,
2005). The protein was heterogeneously phosphorylated with
the predominant species having all four sites occupied (Chen
et al., 2005), which reflects the mobility of IBV N protein
(detected using western blot) during infection, in which a single
N protein species is observed (Dove et al., 2006). Similarly the
porcine coronavirus, transmissible gastroenteritis virus
(TGEV), N protein was also found to be phosphorylated at
two clusters, amino acids Ser156, Ser254 and Ser256 (Calvo et al.,
2005). The murine coronavirus, mouse hepatitis virus N protein
is phosphorylated at Ser170, Thr177, Ser389, Ser424 and Thr428
(White et al., 2007). Although the precise sites have not been
mapped, the SARS-CoV N protein is thought to be phosphory-lated at serine residues (Surjit et al., 2005). Thus for IBV and
MHV N proteins these phosphate groups are located in the
middle and C-terminal regions of the protein, and overall the
IBV, TGEVand MHVanalyses demonstrate that coronavirus N
proteins are phosphorylated but not at multiple (b10) serine
residues which was once accepted dogma based upon prediction
analysis.
Kinetic analysis indicated that phosphorylation of the IBV N
protein played a role in discriminating between non-viral
(random RNA) and IBV RNA (the leader sequence); the
phosphorylated N protein having a high binding affinity for
viral RNA compared to non-viral RNA (Chen et al., 2005). In
contrast, non-phosphorylated N protein bound to either viral or
non-viral RNA with similar affinities (Chen et al., 2005).
However, given the conserved nature of N protein phosphor-
ylation, the role of whether both or single phosphorylation
clusters mediated RNA binding and the general role of phos-
phorylation of N protein in virus biology has not previously been
elucidated and is addressed in this study.
Results and discussion
Generation and characterization of differentially
phosphorylated N proteins
To investigate the role of the phosphorylation clusters in
the binding of IBV N protein to RNA and in the biology of
virus replication, site directed mutagenesis was used to replace
the appropriate amino acid coding sequences in the IBV N
gene sequence in the expression plasmid pTriExIBVN,
generating plasmids pTriExIBVNSSAA, pTriExIBVNAATS and
pTriExIBVNAAAA; all with a C-terminal his-tag coding
sequence for protein purification purposes. Plasmid pTriEx-
IBVN had previously been used to make a recombinant
baculovirus for expressing phosphorylated IBV N protein in
Sf9 cells (referred here as NSSTS) (Chen et al., 2003, 2002).
Previous mass spectroscopic analysis demonstrated that N
protein expressed in insect cells had identical post-transla-
tional modifications to that produced in a cell line (Vero)
permissive to virus infection (Chen et al., 2005). A similar
approach was used in this study to generate recombinant
baculoviruses for the expression of modified IBV N proteins.
The baculoviruses were used to express modified N proteins
in which either Ser190 and Ser192 (NAATS) or Thr
378 and
Ser379 (NSSAA) were substituted for the amino acid alanine
resulting in a partially phosphorylated IBV N protein. A third
recombinant baculovirus was produced that expressed a
modified N protein in which all four amino acids were
substituted for alanine resulting in a non-phosphorylated
(NAAAA) form of the IBV N protein. The NAAAA protein was
used in place of E. coli expressed N protein (non-phos-
phorylated protein) to ensure that any additional post-trans-
lational modifications, such as acetylation, were present.
The modified IBV N proteins were purified by nickel affinity
chromatography and analysis of the recombinant purified
proteins using SDS–PAGE indicated that NSSAA and NAATS
had identical mobility, whereas NAAAA had the fastest mobility
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non-phosphorylated) and NSSTS had the slowest mobility (Fig.
1). These differences in electrophoretic mobility suggested that
the purified proteins were phosphorylated to different extents
and these differences are distinguishable due to the additional
charge that is added to the protein upon phosphorylation. As
predicted NSSAA and NAATS had identical mobility as both
contained two phosphate groups.
To confirm this, native phosphorylated N protein and the
three phosphorylation mutants were subject to in-gel tryptic
digestion and the resulting peptide pools separated using a C18
column and eluent analyzed by electrospray MS/MS. The
analysis confirmed that as in the previous study (Chen et al.,
2005) all four sites on NSSTS could be phosphorylated (data not
shown) and confirmed that on NAAAA Ser
190 and Ser192 and
Thr378 and Ser379 were all replaced with alanine and no other
phosphorylation occurred (data not shown). NSSAA and NAATS
were bi-phosphorylated as the predominant species (data not
shown) which was also reflected in their identical electro-
phoretic mobility (Fig. 1).
Role of phosphorylation clusters in the recognition of IBV RNA
by IBV N protein
SPR analysis was used to investigate the relative role or
contribution of either the region II phosphorylation cluster or
region III phosphorylation cluster in the recognition of RNA by
N protein as described previously (Chen et al., 2005; Spencer
and Hiscox, 2006a). Briefly, the biotinylated RNA sequences
were immobilized separately on a streptavidin sensor chip
(BIAcore) and 3.125, 6.25, 12.5, 25, 50 and 100 nM con-
centrations of the modified IBV N proteins were allowed to
interact with the target RNAs in a liquid phase. Each protein
concentration was injected in duplicate and the experiment
repeated three times. The resultant sensograms were analyzed
using BIAevaluation software (BIAcore) as described pre-
viously (Chen et al., 2005; Spencer and Hiscox, 2006a).Fig. 1. Comparison of the mobility using SDS–PAGE between phosphorylated
IBV N protein (NSSTS), NAATS protein, NSSAA protein, NAAAA protein and N
protein expressed in E. coli (Spencer and Hiscox, 2006a). Molecular weights are
indicated to the right and the appropriate ladder is denoted (M).The data fitted to a 1:1 Langmuir binding model and
indicated that all four IBV N proteins, NSSTS, NSSAA, NSSAA
and NAAAA, had high affinity binding, KD=1.7–3.5 nM, to
the viral-derived RNA, with no significant difference between
the overall binding affinities (Fig. 2, Table 1). The
baculovirus-derived phosphorylated viral N protein (NSSTS)
bound to the viral RNA with high affinity (KD=2.8 nM), but
in contrast bound with approximately 900 times lower affinity
(KD=2510 nM) to the random RNA (Fig. 3, Table 1). This
difference in affinity resulted from decreased association and
increased dissociation rates for random versus viral RNA. The
non-phosphorylated IBV N protein, NAAAA, and the partially
phosphorylated N protein, NSSAA, bound non-viral RNA with
higher affinities. However, the partially phosphorylated N
protein, NAATS, bound non-viral RNA with approximately 246
times lower affinity than the non-phosphorylated NAAAA
protein, with binding kinetics similar to the phosphorylated
NSSTS protein (Fig. 3, Table 1). These data indicated that
phosphorylation of the amino acids Thr378 and Ser379 of
the IBV N protein was involved in discrimination of viral from
non-viral RNA.
In many cases phosphorylation of a capsid protein has been
shown to be involved in regulating RNA binding and in general
two different mechanisms may be in operation. In the first case
phosphorylation through altering charge may affect binding
affinity. For example, dephosphorylation of the rubella virus
capsid protein increases its binding affinity for viral RNA and
specific phosphorylation sites are involved in the process (Law
et al., 2003). This is also the case for IBV N protein where non-
phosphorylated N protein can bind viral RNA with higher
affinity than phosphorylated protein, but at the expense of
specificity. Likewise, phosphorylation has been proposed to
reduce the electrostatic interaction with target RNA, as in the
case of the binding of potato virus A coat protein to RNA
(Ivanov et al., 2001). Given the binding differences between
NAATS protein and NSSAA protein for viral RNA it can be
concluded that overall negative charge is not contributing to
binding, otherwise the two proteins would have equivalent
binding kinetics. Both of these proteins had identical motilities
as determined by SDS–PAGE analysis (Fig. 1), and again mass
spectroscopy confirmed their phosphorylation status with two
phosphorylated sites.
Phosphorylation of N protein does not affect the overall
structure
An alternative mechanism is that phosphorylation can affect
the conformation of a protein with a corresponding effect on
RNA binding properties, as in the case of human immunode-
ficiency virus type 1 Rev protein, where the phosphorylation of
one or two serine residues can cause the closure of an RNA
binding cleft in the protein (Fouts et al., 1997). Similarly,
phosphorylation of the duck hepatitis B virus capsid protein
causes a conformational change in the C-terminal region of the
protein (Yu and Summers, 1994). In order to determine whether
there were any major conformational differences in the N
protein structures between the modified forms of the N proteins
Fig. 2. Kinetic analyses of IBV N protein and the N proteins with modified sites binding to viral RNA. The proteins at 3.125, 6.25, 12.5, 25, 50 and 100 nM
concentrations were injected over the immobilized RNA; association was monitored for 6 min followed by a 12 min dissociation phase. Black lines represent fitted
data. Kinetic parameters for the experiments are shown in Table 1.
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of the Ser or Thr amino acids with Ala, circular dichroism
(CD) spectroscopy was used to determine the conformational
states of the four N proteins. CD spectroscopy results in the
detection of changes in the overall secondary structure of a
protein. CD spectroscopic measurements were taken in the far
UV (180–260 nm) spectra. This was repeated three times for
all four proteins with different protein samples used in each
separate experiment. The HT reading was taken along side all
measurements to ensure that the signal to noise ratio remained
below the level at which data could be considered reliable. An
example of a CD spectrum obtained for all four proteins with theaverage HT reading for all four proteins is shown in Fig. 4. The
resulting data (above a wavelength of 195 nm) indicated that the
differing phosphorylation patterns did not result in different
overall secondary structures, as judged by the similarity of the
four CD readings produced. The spectra of all four proteins
remained below the axis for the majority of the reading, with a
major trough occurring between 200 and 210 nm. One subtle
difference that can be observed is that the CD trace of both the
partially phosphorylated proteins remained slightly closer to the
x-axis (i.e. less negative) between 250 and 200 nm than the same
region of the fully and non-phosphorylated proteins. Despite this
difference in magnitude of the CD signals, the general shapes of
Table 1
Average kinetic parameters for IBV N protein and phosphorylation mutants
interacting with viral and non-viral RNA
kass kdiss KD (nM)
a χ2
Viral RNA
NSSTS 5.5±1.0×10
3 1.6±0.9×10−5 2.8±1.3 6.13
NAATS 5.5±1.3×10
3 1.2±0.6×10−5 2.2±0.7 2.97
NSSAA 5.2±0.7×10
3 8.6±1.3×10−6 1.7±0.7 0.639
NAAAA 2.1±0.4×10
4 7.3±0.9×10−6 3.50±0.84 0.379
Non-viral RNA
NSSTS 9.4±0.6×10
2 2.3±0.1×10−3 2510±18.4 4.9
NAATS 3.1±1.3×10
2 1.4±0.1×10−3 4670±20.7 8.06
NSSAA 2.1±0.7×10
3 2.3±1.3×10−4 111±7.36 10.3
NAAAA 6.8±0.8×10
3 1.3±0.3×10−4 19.1±4.11 11.5
a KD values were calculated from the kdiss and kass ratios (KD=kdiss/kass) and
the errors of KD (EKD) were calculated from the errors of kass (Ekass) and kdiss
(Ekdiss) using the equation
EKD ¼ KD
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ekdiss
kdiss
 2
þ Ekass
kass
 2
:
s
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negative and evoking a major trough peaking at approximately
208 nm was the same as observed in the far CD spectrum of IBV
N protein expressed and purified from E. coli (Spencer and
Hiscox, 2006a).
In order to statistically test the observation that phosphoryla-
tion status did not alter the gross conformation of IBV N protein,
CD data were analyzed by a number of algorithms provided by
the DICHROWEB on-line server (Whitmore and Wallace,
2004). As for previous analysis (Spencer and Hiscox, 2006a) the
CDDSTR (a Fortran program (Johnson, 1999)) provided the best
fitting data, as judged by the low normalized root mean square
deviation (NRMSD) values and close agreement between the
experimental and reconstructed spectra. As such, data estimated
by this method were used to compare the structures of
differentially phosphorylated N proteins (Table 2). The data
indicated that all four proteins were made up of a large pro-
portion of β structures, with β-sheets and turns accounting for
over 50% of the secondary structure. The proteins contained an
average of 20% α-helix with the remaining 26–27% being
comprised of random coil structures, again these are consistent
with those estimations of secondary structure for (non-
phosphorylated) N protein expressed in E. coli (Spencer and
Hiscox, 2006a). The Student's t-test revealed that any difference
between the secondary structure elements of the differentially
phosphorylated B proteins was not significant (data not shown).
These proportions are in approximate agreement with the solid
state structure for the N and C-terminal regions of IBV N protein
(Jayaram et al., 2006).
Ability of differentially phosphorylated N protein to rescue
infectious IBV from cDNA
To investigate whether the phosphorylation status of N
protein played a role in the biology of IBV this study utilized
modified IBV N proteins to rescue infectious IBV using thereverse genetics system for IBV (Fig. 5), as described (Casais
et al., 2003, 2001). N protein is essential for the successful
rescue of IBV using at least two different types of reverse
genetics systems (Britton et al., 2005; Casais et al., 2001;
Youn et al., 2005a,b). Recovery of infectious IBV was
repeatedly found to be unsuccessful in the absence of the
IBV N protein or from the use of an IBV N gene that lacked
the correct initiation codon for the N protein. However,
infectious IBV was rescued via co-transfection of plasmid
DNA expressing either IBV NSSTS, NSSAA, NAATS or NAAAA
(pCi-NeoIBVNSSTS, pCi-NeoIBVNSSAA, pCi-NeoIBVNAATS
and pCi-NeoIBVNAAAA, respectively) and vaccinia virus
DNA containing a full-length IBV cDNA under the control of
a T7 promoter sequence in chick kidney cells previously
infected with a recombinant fowlpox virus expressing T7 RNA
polymerase. The rescue experiments were repeated three times.
The amounts of progeny virus rescued in the transfected cells
were determined by plaque assay, as an approximate determina-
tion of the efficiency of rescue, and related to input plasmid,
generating a numerical output of infectious units per μg of input
plasmid. All of the modified N proteins resulted in the rescue of
infectious IBV, indicating that phosphorylation of the IBV N
protein is not required for this biological activity. However,
analysis of the rescue of infectious IBV indicated that the IBV N
proteins NSSTS, NSSAA, NAATS and NAAAA, generated 3200±
154, 25±6, 680±17 and 68±9 infectious units per μg of input
plasmid, respectively.
As controls, plasmids in which the initiation codon, AUG,
of N protein had been mutated and therefore did not express the
IBV N protein or plasmids expressing the influenza virus
nucleoprotein (pcDNA2.1-NP-wt) or the bovine viral diarrhea
virus capsid protein (pEF6A-BVDV-capsid) were incapable of
rescuing infectious IBV (data not shown). This indicated that
although the phosphorylated form of the IBV N protein was not
required for rescue of IBV it was, however, more efficient for
rescue, when compared to partially phosphorylated or non-
phosphorylated forms of the N protein, indicating some role for
phosphorylation. It should be noted that the modification of the
N protein, either by loss of the phosphate moiety or substitution
of a Ser or Thr amino acid by alanine, did not affect the
stability of N protein as determined by immunofluorescence
(data not shown). The absence of any IBV N protein did not
result in rescue.
The effect of the modified N protein was only transient as
replication of the IBV infectious RNA, generated from the
IBV cDNA by the T7 RNA polymerase, would ultimately
lead to the generation of subgenomic mRNA capable of
expressing wild-type N protein. The fact that IBV N protein is
essential for rescue supports the observation that modified N
proteins were still capable of initiating rescue and that phos-
phorylation is not absolutely required for this role. Interest-
ingly, loss of the Thr378 and Ser379 phosphorylation site
NAATS compared to NSSAA protein resulted in a 20-fold de-
crease in rescue potentially indicating a more dominant role
for this cluster site. Interestingly, this cluster site was also
dominant in discriminating binding of the N protein to non-
viral-derived RNA.
Fig. 3. Kinetic analyses of IBV N protein and the N proteins with modified phosphorylation sites binding to non-viral RNA. The proteins at 3.125, 6.25, 12.5, 25, 50
and 100 nM concentrations were injected over the immobilized RNA; association was monitored for 6 min followed by a 12 min dissociation phase. Black lines
represent fitted data. Kinetic parameters for the experiments are shown in Table 1.
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IBV N protein may play a role in the virus life cycle and that the
Thr378 and Ser379 residues appear to have the greatest influence
on this role from the RNA binding studies and the ability of IBV
N protein to initiate rescue of infectious virus from cDNA.
These residues are located in the C-terminal region of the
protein, the structure of which has been partially solved by X-
ray crystallography using the Gray strain of IBV (Jayaram et al.,
2006). Unfortunately, the portion of the protein for which the
structure was solved encompasses residues 219 to 349
inclusive. The Thr378 and Ser379 residues lay outside of thisfragment, and as such their position on the three dimensional
model cannot be mapped. However, this region of the protein is
reported to be stable and to contain a number of conserved
residues (Jayaram et al., 2006), for example a nuclear export
signal (Reed et al., 2007) which is shared with the SARS-CoV
N protein (You et al., 2007). The Ser190 and Ser192 residues lie
within the central region of the protein, the structure of which
has not been elucidated. This region of the protein has been
reported as intrinsically highly disordered (Enjuanes et al.,
2006b; Jayaram et al., 2006) and as such difficult to purify and
perform structural analysis. The observation that phosphoryla-
Fig. 4. CD spectroscopy of the IBV N proteins. The IBV N protein (NSSTS) is
shown by an unbroken black line, the modified N proteins, NAAAA protein by a
black dotted line, NAATS protein by a gray dotted line and NSSAA protein by a
gray unbroken line. All the CD spectra were determined at the far UV (195–
260 nm) wavelength. Shown beneath is the voltage at a given absorbance
(continuous line).
Fig. 5. Diagrammatic strategy for the recovery of infectious IBV from a full-
length cDNA template. Expression of the IBV N protein from an expression
plasmid is essential for the successful rescue of infectious IBV. Vaccinia virus
DNA, containing the full-length IBV cDNA, and the plasmid expressing the
IBV N genes are co-transfected into chick kidney cells previously infected with
a recombinant fowlpox virus expressing T7 RNA polymerase. Expression of T7
RNA polymerase from the recombinant fowlpox virus results in the synthesis of
infectious IBV RNA from the vaccinia virus DNA. The IBV RNA acts as an
mRNA for the synthesis of the IBV replicase proteins, resulting in replication of
the IBV RNA and generation of the subgenomic mRNAs for translation of the
structural proteins and assembly of infectious virus progeny. The expression of
IBV N protein from the co-transfected plasmid is required to initiate this process
by an as yet unknown mechanism.
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RNA binding ability than those in the structured C-terminal
region indicates that the central region of the protein may indeed
be unstructured and that changes, such as phosphorylation, have
little effect on the function in this part of the protein.
Overall the phosphorylation status of IBV N protein has a
dramatic influence on RNA binding capability and virus
biology and that phosphorylation of only a small number of
residues confers to N protein the ability to distinguish viral
RNA from non-viral RNA. The mechanism by which this
biological process occurs remains elusive, however, changes in
RNA binding caused by a gross conformational change, upon
phosphorylation of the protein, can be ruled out as playing a role
in this complex viral process.
Materials and methods
Recombinant plasmids and baculoviruses
The IBV N protein was cloned C-terminal of a his-tag for
expression in E. coli and insect cells as described previously
(Chen et al., 2003, 2005). This plasmid served as template forTable 2
Calculation of secondary structure elements of differentially phosphorylated
IBV N protein
α-Helix β-Sheet β-Turn Random coil NMRSD
NSSTS 20±4 33±7 21±6 26±4 0.051
NAATS 21±3 30±5 23±3 26±2 0.016
NSSAA 20±2 31±4 22±5 17±1 0.034
NAAAA 18±2 33±8 22±4 27±2 0.021
Analysis was performed using the CDSSTR method of three separate readings
and averages calculated; errors are displayed as deviation from the mean.the generation of plasmids that when expressed would lead to
phosphorylation mutants of N protein. Specific mutations
were introduced using the Stratagene QuikChange site
directed mutagenesis kit. Three plasmids were generated
pTriExIBVNSSAA, pTriExIBVNAATS and pTriExIBVNAAAA,
which lead to the replacement of Thr378 and Ser379 with
alanine, Ser190 and Ser192 with alanine and Ser190, Ser192,
Thr378 and Ser379 with alanine, respectively. Primer sequences
are available on request. All constructs were sequenced in both
directions. Recombinant baculoviruses were generated by
transfecting Sf9 cells with the plasmids expression vector
(which contained segments of baculovirus genomic DNA) and
BacVector-3000 Triple Cut Virus DNA (Novagen). After
transfection, monolayers were plaque assayed and candidate
plaques individually purified by re-plaquing. Virus was
harvested from subsequent plaques and used to infect exponen-
tially growing cultures of Sf9 cells. These modified N protein
genes were also cloned into the eukaryotic expression plasmid
pCi-Neo that did not contain a his-tag moiety for rescue of
infectious IBV as described (Casais et al., 2003, 2001). These
vectors were pCi-NeoIBVNSSAA, pCi-NeoIBVNAATS and pCi-
NeoIBVNAAAA. The cloning of wild-type N protein into pCi-
Neo (in this study referred to as pCi-NeoIBVNSSTS) has been
described previously (Hiscox et al., 2001).
Expression and purification of recombinant protein from Sf9
cells
Sf 9 suspension cells were infected with the appropriate
baculovirus expressing either the wild-type N protein or mutant
N protein at an MOI of 5. Cultures were grown for 48 h and cell
pellets were harvested by centrifugation. Cell pellets were
380 K.-A. Spencer et al. / Virology 370 (2008) 373–381resuspended in RIPA lysis buffer and insoluble debris removed
by high speed centrifugation. The soluble fraction containing the
N protein was purified using column chromatography as
described (Chen et al., 2003, 2005; Spencer and Hiscox, 2006b).
Surface plasmon resonance (SPR)
SPR measurements were conducted on a Biacore3000
instrument as previously described (Chen et al., 2005) and
data fitted to a 1:1 Langmuir model. Briefly, a biotinylated RNA
was immobilized on a streptavidin sensor chip (BIAcore) and
varying concentrations of the N protein or mutants passed over,
with a flow rate of 30 μl/min. Mass transport analysis
experiments were conducted as described previously and no
effects were observed.
RNA synthesis
Two RNA templates were used for SPR analysis in this study.
In this system the IBV subgenomic mRNA 3 leader sequence
was used as a viral target for N protein. The chemically
synthesized RNA consisted of a biotin group at the 5′ end
followed by the 90 nucleotide leader sequence up to and
including a translation initiation codon (Chen et al., 2005;
Spencer and Hiscox, 2006a,b). Biotin-ACUUAAGAUAGA-
UAUUAAUAUAUAUCUAUUACACUAGCCUUGCGCUA-
GAUUUUUAACUGAACAAUACAGACCUAAAAAGUCU-
GUUUGAUG. The TRS is shown in bold face. The non-viral
RNA was synthesized by in vitro transcription and biotin was
incorporated at the 5′ end as part of this reaction. The sequence
was GGGAGCUCCAGAAGAUAAAUUACAGG-UCGUAG-
CAUAGUUAUUAGUCCAGAGAUGUUGAGA-GAUA-
CAGCGCAGUCUCCAACUAGGAUACUAUG-ACCCC.
Circular dichroism
CD experiments were performed on a Jasco J715 spectro-
photometer. Protein samples to be analyzed were dialyzed into
20 mM sodium phosphate buffer, pH 7.2. Measurements were
taken in the far-UV (195–260 nm) and the CD signal recorded
in a 1-mm path-length cell using a protein concentration of 0.4,
0.6 and 0.8 mg/ml with eight accumulations.
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